The fundraising will provide significant capital to fuel the company’s expansion plans. The Company plans to use capital to expand the current network of 150+ centers to 300+ centers over the next three years. The Company has new projects under development in Mumbai, Punjab, Central and North India, among others. The company continues to experience growth and success in its key markets including Tamil Nadu, Karnataka, Maharashtra, Gujarat, Punjab, Telangana, Andhra Pradesh, Kerala and West Bengal.

The fundraising will provide significant capital to fuel the company’s expansion plans. The Company plans to use capital to expand the current network of 150+ centers to 300+ centers over the next three years. The Company has new projects under development in Mumbai, Punjab, Central and North India, among others. The company continues to experience growth and success in its key markets including Tamil Nadu, Karnataka, Maharashtra, Gujarat, Punjab, Telangana, Andhra Pradesh, Kerala and West Bengal.

In addition to expanding the network, the company will also invest in technological advances in vision correction such as SMILE, laser cataract surgery and in advanced technologies to treat diseases of the vitreous retina such as diabetic retinopathy and age-related macular degeneration.

In addition to expanding the network, the company will also invest in technological advances in vision correction such as SMILE, laser cataract surgery and in advanced technologies to treat diseases of the vitreous retina such as diabetic retinopathy and age-related macular degeneration.

The shares of Dr. Agarwal’s Eye Hospitals rose as much as 10.3% on the announcement but then gave up some gains to climb 4.2% in last trade.

The shares of Dr. Agarwal’s Eye Hospitals rose as much as 10.3% on the announcement but then gave up some gains to climb 4.2% in last trade.

Prof. (Dr.) Amar Agarwal, Chairman of Dr best practices from different sectors while relying on continuous innovation and cutting-edge technology to serve our patients. The new investments will be used to expand our presence in India and internationally while acquiring the latest technologies in highly specialized eye care.”

Prof. (Dr.) Amar Agarwal, Chairman of Dr best practices from different sectors while relying on continuous innovation and cutting-edge technology to serve our patients. The new investments will be used to expand our presence in India and internationally while acquiring the latest technologies in highly specialized eye care.”

“We continue to be excited about the company’s growth potential and share the company’s vision to deliver world-class clinical results coupled with compelling financial performance. “Dr. Agarwal’s has the potential to become a global leader in the eye care segment,” said Ankur Thadani, Business Unit Partner at TPG Growth.

“We continue to be excited about the company’s growth potential and share the company’s vision to deliver world-class clinical results coupled with compelling financial performance. “Dr. Agarwal’s has the potential to become a global leader in the eye care segment,” said Ankur Thadani, Business Unit Partner at TPG Growth.

dr Adil Agarwal, CEO of Dr. Agarwal Group of Eye Hospitals, added: “The investment will be used to support the business in its next phase of growth, including the acquisition of small hospitals and chains as well as expanding our greenfield network.” to double over the next three years and also to expand intensively in Maharashtra, Punjab, Delhi, Uttar Pradesh and Central India as well as to penetrate deeper into our existing markets. In addition, we will build over 100 primary eye hospitals in Tier 2 and Tier 3 cities over the next few years. Africa is another important geography for us. We already have a network presence of 15 hospitals and will expand our presence in Kenya, Zambia and Tanzania and intend to add 10 centers in those countries.”

dr Adil Agarwal, CEO of Dr. Agarwal Group of Eye Hospitals, added: “The investment will be used to support the business in its next phase of growth, including the acquisition of small hospitals and chains as well as expanding our greenfield network.” to double over the next three years and also to expand intensively in Maharashtra, Punjab, Delhi, Uttar Pradesh and Central India as well as to penetrate deeper into our existing markets. In addition, we will build over 100 primary eye hospitals in Tier 2 and Tier 3 cities over the next few years. Africa is another important geography for us. We already have a network presence of 15 hospitals and will expand our presence in Kenya, Zambia and Tanzania and intend to add 10 centers in those countries.”

Veda Corporate Advisors acted as financial advisor to Dr. Agarwal’s Health Care Ltd.

Veda Corporate Advisors acted as financial advisor to Dr. Agarwal’s Health Care Ltd.

dr Agarwal’s Eye Hospital Group was established in 1957 as a single facility in Chennai. The group is led by the chair Prof. (Dr.) Amar Agarwal. He is a pioneer in the field of ophthalmology and is known for several breakthrough surgical innovations such as bonded IOL, PDEK and PhakoNit. dr Agarwal’s Eye Hospitals now has a total network of 151 centers (140 hospitals and 11 eye clinics) spread across India and Africa. The group’s presence spans 10 countries and 14 states in India

dr Agarwal’s Eye Hospital Group was established in 1957 as a single facility in Chennai. The group is led by the chair Prof. (Dr.) Amar Agarwal. He is a pioneer in the field of ophthalmology and is known for several breakthrough surgical innovations such as bonded IOL, PDEK and PhakoNit. dr Agarwal’s Eye Hospitals now has a total network of 151 centers (140 hospitals and 11 eye clinics) spread across India and Africa. The group’s presence spans 10 countries and 14 states in India